Close Menu

NEW YORK ─ GenMark Diagnostics said Wednesday that it has priced an approximately $70 million public offering of its common stock. Separately, Chembio Diagnostics said it has priced a $27.5 million offering of its common stock.

Carlsbad, California-based GenMark said it expects to sell 7,253,886 shares at $9.65 per share. It has granted the underwriters of the offering a 30-day option to purchase up to an additional 1,088,082 shares at the public offering price, less underwriting discounts and commissions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.